{"pmid":32395423,"pmcid":"PMC7211620","title":"Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report.","text":["Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report.","It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms. Our report shows that IPA may occur in critically ill COVID-19 patients.","Med Mycol Case Rep","Prattes, Juergen","Valentin, Thomas","Hoenigl, Martin","Talakic, Emina","Reisinger, Alexander C","Eller, Philipp","32395423"],"abstract":["It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms. Our report shows that IPA may occur in critically ill COVID-19 patients."],"journal":"Med Mycol Case Rep","authors":["Prattes, Juergen","Valentin, Thomas","Hoenigl, Martin","Talakic, Emina","Reisinger, Alexander C","Eller, Philipp"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395423","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.mmcr.2020.05.001","keywords":["aspergillosis","covid-19","icu"],"topics":["Case Report"],"weight":1,"_version_":1666627827935477760,"score":9.490897,"similar":[{"pmid":32487793,"title":"Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.","text":["Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.","Invasive pulmonary aspergillosis (IPA) is a life-threatening condition that usually occurs in immunocompromised hosts. However, according to recent reports it can affect immunocompetent hosts with severe influenza infection due to viral-dependent disruption of respiratory immune defenses. We present the case of a 61-year-old Caucasian man admitted to the Emergency Department with respiratory failure and fever, who was diagnosed with H1N1 influenza and IPA. Because of his poor general conditions, he was treated with a double antifungal scheme, although this lies outside the suggested treatment guidelines. This choice turned out to be extremely effective. He was discharged after one month and his clinical conditions showed rapid improvement, with nearly complete normalization of the radiological pattern in three months. IPA remains a life-threatening condition, even in immunocompetent hosts, and should therefore always be suspected; if necessary, a combined treatment should rapidly be started. We report this case as the interest in influenza-associated IPA is high, both due to the clinical severity of this condition, which is treatable if identified early, and the emerging importance of respiratory infections caused by viruses belonging to the SARS family, such as SARS-CoV-2.","Infez Med","Saccaro, Luigi Francesco","Galfo, Valentina","Ferranti, Simone","Russo, Alessandro","Menichetti, Francesco","32487793"],"abstract":["Invasive pulmonary aspergillosis (IPA) is a life-threatening condition that usually occurs in immunocompromised hosts. However, according to recent reports it can affect immunocompetent hosts with severe influenza infection due to viral-dependent disruption of respiratory immune defenses. We present the case of a 61-year-old Caucasian man admitted to the Emergency Department with respiratory failure and fever, who was diagnosed with H1N1 influenza and IPA. Because of his poor general conditions, he was treated with a double antifungal scheme, although this lies outside the suggested treatment guidelines. This choice turned out to be extremely effective. He was discharged after one month and his clinical conditions showed rapid improvement, with nearly complete normalization of the radiological pattern in three months. IPA remains a life-threatening condition, even in immunocompetent hosts, and should therefore always be suspected; if necessary, a combined treatment should rapidly be started. We report this case as the interest in influenza-associated IPA is high, both due to the clinical severity of this condition, which is treatable if identified early, and the emerging importance of respiratory infections caused by viruses belonging to the SARS family, such as SARS-CoV-2."],"journal":"Infez Med","authors":["Saccaro, Luigi Francesco","Galfo, Valentina","Ferranti, Simone","Russo, Alessandro","Menichetti, Francesco"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487793","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["Caucasian"],"topics":["Case Report"],"weight":1,"_version_":1668623433744777216,"score":309.17407},{"pmid":32343223,"title":"Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.","text":["Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.","Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe influenza pneumonia. We report a fatal case of invasive pulmonary aspergillosis in an immunocompetent patient in France who had severe coronavirus disease-associated pneumonia.","Emerg Infect Dis","Blaize, Marion","Mayaux, Julien","Nabet, Cecile","Lampros, Alexandre","Marcelin, Anne-Genevieve","Thellier, Marc","Piarroux, Renaud","Demoule, Alexandre","Fekkar, Arnaud","32343223"],"abstract":["Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe influenza pneumonia. We report a fatal case of invasive pulmonary aspergillosis in an immunocompetent patient in France who had severe coronavirus disease-associated pneumonia."],"journal":"Emerg Infect Dis","authors":["Blaize, Marion","Mayaux, Julien","Nabet, Cecile","Lampros, Alexandre","Marcelin, Anne-Genevieve","Thellier, Marc","Piarroux, Renaud","Demoule, Alexandre","Fekkar, Arnaud"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343223","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3201/eid2607.201603","keywords":["aspergillus","covid-19","sars","sars-cov-2","aspergillosis","coronavirus","coronavirus disease","fungal superinfection","fungi","intensive care unit","mechanical ventilation","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Case Report"],"weight":1,"_version_":1666138495068930048,"score":235.2124},{"pmid":32339350,"title":"COVID-19 Associated Pulmonary Aspergillosis.","text":["COVID-19 Associated Pulmonary Aspergillosis.","OBJECTIVES: Patients with acute respiratory distress syndrome (ARDS) due to viral infection are at risk for secondary complications like invasive aspergillosis. Our study evaluates Coronavirus disease 19 (COVID-19) associated invasive aspergillosis at a single center in Cologne, Germany. METHODS: A retrospective chart review of all patients with COVID-19 ARDS admitted to the medical or surgical intensive care unit at the University Hospital of Cologne, Germany. RESULTS: COVID-19 associated invasive pulmonary aspergillosis was found in five of 19 consecutive critically ill patients with moderate to severe ARDS. CONCLUSION: Clinicians caring for patients with ARDS due to COVID-19 should consider invasive pulmonary aspergillosis and subject respiratory samples to comprehensive analysis to detect co-infection.","Mycoses","Koehler, Philipp","Cornely, Oliver A","Bottiger, Bernd W","Dusse, Fabian","Eichenauer, Dennis A","Fuchs, Frieder","Hallek, Michael","Jung, Norma","Klein, Florian","Persigehl, Thorsten","Rybniker, Jan","Kochanek, Matthias","Boll, Boris","Shimabukuro-Vornhagen, Alexander","32339350"],"abstract":["OBJECTIVES: Patients with acute respiratory distress syndrome (ARDS) due to viral infection are at risk for secondary complications like invasive aspergillosis. Our study evaluates Coronavirus disease 19 (COVID-19) associated invasive aspergillosis at a single center in Cologne, Germany. METHODS: A retrospective chart review of all patients with COVID-19 ARDS admitted to the medical or surgical intensive care unit at the University Hospital of Cologne, Germany. RESULTS: COVID-19 associated invasive pulmonary aspergillosis was found in five of 19 consecutive critically ill patients with moderate to severe ARDS. CONCLUSION: Clinicians caring for patients with ARDS due to COVID-19 should consider invasive pulmonary aspergillosis and subject respiratory samples to comprehensive analysis to detect co-infection."],"journal":"Mycoses","authors":["Koehler, Philipp","Cornely, Oliver A","Bottiger, Bernd W","Dusse, Fabian","Eichenauer, Dennis A","Fuchs, Frieder","Hallek, Michael","Jung, Norma","Klein, Florian","Persigehl, Thorsten","Rybniker, Jan","Kochanek, Matthias","Boll, Boris","Shimabukuro-Vornhagen, Alexander"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339350","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/myc.13096","keywords":["aspergillus","ecmo","icu","sars-cov-2","isavuconazole","voriconazole"],"locations":["Cologne","Germany","Germany"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Treatment"],"weight":1,"_version_":1666138494201757698,"score":194.15598},{"pmid":32466326,"title":"The Impact of COVID-19 on Tourist Satisfaction with B&B in Zhejiang, China: An Importance-Performance Analysis.","text":["The Impact of COVID-19 on Tourist Satisfaction with B&B in Zhejiang, China: An Importance-Performance Analysis.","After the outbreak of COVID-19 (especially in the stage of tourism recovery), the bed and breakfast (B&B) tourism industry faced big challenges in improving its health strategies. B&Bs are very important for the tourism industry in China and many other countries. However, few studies have studied the impact of B&Bs, under COVID-19, on tourism in China. Our paper is among one of the first studies to investigate the impact of COVID-19 on tourist satisfaction with B&Bs in China. The work/travel restrictions started from 20 January 2020, and work/after travel resumed from 20 February 2020 in Zhejiang, China. Data were collected from 588 tourists (who experienced B&Bs in Zhejiang, China) from a WeChat online survey, from 1 March to 15 March 2020. The current study attempted to fill the gap by studying the changing tourist satisfaction levels with B&Bs before/after COVID-19. Moreover, some suggestions are given to the B&B industry for tourism resumption after COVID-19 by an importance-performance analysis (IPA).","Int J Environ Res Public Health","Hong, Yan","Cai, Gangwei","Mo, Zhoujin","Gao, Weijun","Xu, Lei","Jiang, Yuanxing","Jiang, Jinming","32466326"],"abstract":["After the outbreak of COVID-19 (especially in the stage of tourism recovery), the bed and breakfast (B&B) tourism industry faced big challenges in improving its health strategies. B&Bs are very important for the tourism industry in China and many other countries. However, few studies have studied the impact of B&Bs, under COVID-19, on tourism in China. Our paper is among one of the first studies to investigate the impact of COVID-19 on tourist satisfaction with B&Bs in China. The work/travel restrictions started from 20 January 2020, and work/after travel resumed from 20 February 2020 in Zhejiang, China. Data were collected from 588 tourists (who experienced B&Bs in Zhejiang, China) from a WeChat online survey, from 1 March to 15 March 2020. The current study attempted to fill the gap by studying the changing tourist satisfaction levels with B&Bs before/after COVID-19. Moreover, some suggestions are given to the B&B industry for tourism resumption after COVID-19 by an importance-performance analysis (IPA)."],"journal":"Int J Environ Res Public Health","authors":["Hong, Yan","Cai, Gangwei","Mo, Zhoujin","Gao, Weijun","Xu, Lei","Jiang, Yuanxing","Jiang, Jinming"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466326","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/ijerph17103747","keywords":["covid-19","bed and breakfast (b&b)","importance-performance analysis (ipa)","tourism resumption","tourist satisfaction"],"locations":["China","China","China","Zhejiang","China","Zhejiang","China","Zhejiang","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668420887167107072,"score":112.03441},{"pmid":32462990,"title":"COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.","text":["COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.","COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse.","Vasa","Galastri, Francisco Leonardo","Valle, Leonardo Guedes Moreira","Affonso, Breno Boueri","Silva, Marcela Juliano","Garcia, Rodrigo Gobbo","Junior, Milton Rodrigues","Ferraz, Leonardo Jose Rolim","de Matos, Gustavo Faissol Janot","de la Cruz Scarin, Farah Christina","Nasser, Felipe","32462990"],"abstract":["COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse."],"journal":"Vasa","authors":["Galastri, Francisco Leonardo","Valle, Leonardo Guedes Moreira","Affonso, Breno Boueri","Silva, Marcela Juliano","Garcia, Rodrigo Gobbo","Junior, Milton Rodrigues","Ferraz, Leonardo Jose Rolim","de Matos, Gustavo Faissol Janot","de la Cruz Scarin, Farah Christina","Nasser, Felipe"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462990","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1024/0301-1526/a000880","keywords":["covid-19","anticoagulants","mechanical thrombolysis","pulmonary embolism","thrombectomy"],"topics":["Case Report"],"weight":1,"_version_":1668079521301004288,"score":91.39213}]}